Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Tata Elxsi Ltd
| Q2 FY 2025-26 Earnings Conference Call
Summary : Tata Elxsi delivered modest Q2 growth, anticipates stronger H2 and future double-digit growth in key verticals, despite market volatility and specific segment challenges.
Management Perspective positive : Management expressed strong confidence in H2 performance, future double-digit growth, and margin recovery. Phrases like 'very positive,' 'pretty confident,' and 'gung-ho' were used.
Concall Report Analysis & Insights
Business Overview
- Q2 FY26 operating revenue was INR 918.1 crores, growing 2.9% in actual currencies QoQ.
- EBITDA stood at INR 193.3 crores (21.1% margin), PBT at INR 214.7 crores (22.2% margin).
- U.S. market led overseas growth at 7.9% QoQ despite overall market volatility.
- Media & Communication grew 6.8% sequentially, driven by large deal ramp-ups and new wins.
- Transportation business grew 0.7%, with robust pipeline from global OEM SDV programs.
Future Growth Prospects
- H2 FY26 is expected to be significantly better than H1, with margin recovery.
- Automotive and Healthcare segments aim for double-digit growth in FY27.
- Secured a multi-year, multi-million dollar deal with Bayer for medical devices.
- Transportation business sees strong traction in Europe, Japan, and India.
- Focus on AI data centers and edge computing for AI-powered enterprise applications.
Management Insights
- H2 will be much better than H1, with confidence in spending returning in automotive.
- Margins are slowly recovering; targeting 75% utilization by year-end, 80% next year.
- Offshoring trend benefits Tata Elxsi due to strong capabilities and experience.
- New deals in automotive focus on software-defined vehicles, electrification, and AD/ADAS.
- Media & Communication growth will moderate in H2 due to industry stress and M&A.
Signs of Skepticism
- Media & Communication segment growth is expected to moderate in H2 due to industry stress.
- Attrition levels have marginally increased for the third consecutive quarter.
- U.S. automotive market remains muted, with clarity expected in the next half-year.
- Challenges exist for new-age OEMs and traditional OEMs regarding EV incentives.
- The impact of tariffs and competition from China still causes European OEMs to seek cost-saving outsourcing.
Risk Factors
- Industry environment remains volatile with business restructuring and M&A in Media & Communication.
- Cybersecurity incident with a top auto client impacted Q2 project starts and growth.
- Healthcare and Life Sciences declined 2.3% due to conclusion of large regulatory programs.
- U.S. automotive market remains muted, impacting overall transportation growth.
- Withdrawal of EV incentives and relaxed emission norms affect OEM portfolio resets.
Good To Know
- Launched MBC Now, a Saudi Arabia content aggregator, powered by Tata Elxsi's TEPlay OTT platform.
- Opened a second engineering center with Suzuki focusing on cloud hardware and SDV transition.
- Awarded by Dell Technologies for Best Infrastructure Solutions Group supplier category.
- Launched a Dedicated Technology Center for Bayer devices and Radiology for advanced diagnosis.
- Company has its own mini-NVIDIA data center for AI experimentation and workloads.
Key Drivers
- Strong H2 growth expected.
- New multi-year deals secured.
- Utilization targets to improve margins.
- AI/GenAI adoption drives innovation.
Key Analyst Discussions
Competitive Environment
- Tata Elxsi is a preferred vendor for offshoring due to its capabilities and experience.
- Company is not directly competing with Chinese manufacturers, but benefits from OEMs competing with them.
- German OEMs are investing to compete with Chinese rivals by building more features.
- Tata Elxsi has a minuscule presence in China, as the market is very different.
- Vendor consolidation is less prevalent in automotive; OEMs seek technology, not just cheapest vendor.
Market Trends & Consumer Behavior
- Automotive R&D spend is expected to return, with H2 better than H1.
- Europe and Japan show good traction in automotive, while the U.S. is muted.
- Withdrawal of EV incentives and relaxed emission norms in the U.S. cause portfolio resets.
- Europe remains focused on 55% carbon emission reduction by 2030.
- Offshoring is increasing as European OEMs seek best-cost locations to do more with less.
Financial Highlights
- Q2 saw 90 bps gain from favorable currency, offset by 40 bps higher employee costs.
- Other expenses for AI infrastructure and partnerships impacted margins by 30 bps.
- PBT increased by 110 bps sequentially due to hedging gains and R&D credit.
- Depreciation is declining due to no new significant capex, expected for 2 more quarters.
- Full-year effective tax rate is projected to be around 26% to 26.5%.
Product Composition
- Automotive focus is on software-defined vehicles, electrification, AD/ADAS, and infotainment.
- Seeing a revival in traditional powertrain ICE-related areas as well.
- Healthcare business is primarily US-driven, with some presence in Europe.
- Company focuses on software for semiconductor platforms, not chip design itself.
- AI/GenAI applications aim for productivity, quality, and cost benefits, and new features.
Strategic Considerations
- Europe is the largest automotive market, followed by the U.S., Japan, and India.
- Evaluating opportunities in China, currently a small market for the company.
- Bayer deal is a multi-year, multi-million dollar relationship providing business stability.
- Customer concentration is improving in automotive and healthcare with multiple large deals.
- AI use cases include predictive analytics for radiology and early disease detection.